Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-25-165127
Filing Date
2025-07-25
Accepted
2025-07-25 11:33:58
Documents
1
Effectiveness Date
2025-07-25

Document Format Files

Seq Description Document Type Size
1 S-8 POS d948791ds8pos.htm S-8 POS 23049
  Complete submission text file 0001193125-25-165127.txt   24111
Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Filer) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-270207 | Film No.: 251150185
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)